Opinion|Videos|December 5, 2025

Introductions

Panelists introduce key CDK4/6 inhibitor data from ESMO 2025, setting the stage for insightful discussions on pivotal clinical trials and questions.

Episodes in this series

In this opening segment, the panelists introduce themselves and set the stage for the series, outlining the purpose of the discussion and the key CDK4/6 inhibitor data featured at ESMO 2025. Viewers are oriented to the trials that will anchor the conversation and the clinical questions the experts aim to explore throughout the program.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME